Lipella Pharmaceuticals Inc.
LIPO· Unspecified
LIPOLipella Pharmaceuticals Inc.
Quarterly figures for Lipella Pharmaceuticals Inc., with source filings when available.
15 quarters. Mar 31, 2022 to Sep 30, 2025. USD.
Lipella Pharmaceuticals Inc. has filed its 10-Q within 39 to 45 days of period end across its last 8 quarters. The 10-K runs 58 to 90 days.
Lipella Pharmaceuticals Inc. · CIK 1347242 · Engraved from SEC EDGAR
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Source trail |
|---|---|---|---|---|---|---|---|---|---|
| FY 2025 | |||||||||
| Q3 2025 | Sep 30, 2025 | — | Nov 14, 2025 | 45 d | 10-Q | $0.00 | −100.0% | -$0.28 | |
| Q2 2025 | Jun 30, 2025 | — | Aug 14, 2025 | 45 d | 10-Q | $86.73K | −36.4% | -$0.31 | |
| Q1 2025 | Mar 31, 2025 | — | May 14, 2025 | 44 d | 10-Q | $129.39K | −11.3% | -$0.64 | |
| FY 2024 | |||||||||
| Q4 2024derived | Dec 31, 2024 | — | Mar 28, 2025 | 87 d | 10-K | $173.67K | +43.7% | — | |
| Q3 2024 | Sep 30, 2024 | — | Nov 14, 2024 | ||||||
| FY 2023 | |||||||||
| Q4 2023derived | Dec 31, 2023 | — | Feb 27, 2024 | 58 d | 10-K | $120.84K | −20.0% | — | |
| Q3 2023 | Sep 30, 2023 | — | Nov 14, 2023 | ||||||
| FY 2022 | |||||||||
| Q4 2022derived | Dec 31, 2022 | — | Mar 31, 2023 | 90 d | 10-K | $151.01K | — | — | |
| Q3 2022 | Sep 30, 2022 | — | — | — | |||||
| 45 d |
| 10-Q |
| $80.38K |
| −22.7% |
| -$1.29 |
| Q2 2024 | Jun 30, 2024 | — | Aug 13, 2024 | 44 d | 10-Q | $136.43K | +27.9% | -$0.99 |
|---|
| Q1 2024 | Mar 31, 2024 | — | May 9, 2024 | 39 d | 10-Q | $145.88K | +23.6% | -$1.31 |
|---|
| 45 d |
| 10-Q |
| $104.05K |
| — |
| -$1.84 |
| Q2 2023 | Jun 30, 2023 | — | Aug 14, 2023 | 45 d | 10-Q | $106.68K | — | -$0.27 |
|---|
| Q1 2023 | Mar 31, 2023 | Apr 3, 2023 · after-hours | May 12, 2023 | 42 d | 10-Q | $118.05K | +256.1% | -$0.19 |
|---|
| — |
| $0.00 |
| — |
| -$0.17 |
| Q2 2022 | Jun 30, 2022 | — | — | — | — | $0.00 | — | -$0.20 |
|---|
| Q1 2022 | Mar 31, 2022 | — | — | — | — | $33.15K | — | -$0.19 |
|---|
